|
|
|
|
BioTech Alliances Announces New U.S. Headquarters in California San Francisco Bay Area
Novato, CA Biotech Alliances, an international biotechnology alliances and partnering firm that specializes in facilitating successful strategic alliances to foster growth and advancement in the biotechnology industry, announced today it has...
|
|
|
SIRIM Forges Tie-Up With Egypt's Bird In Marine Biotech
KUALA LUMPUR, March 22 (Bernama) -- SIRIM Bhd has signed a memorandum of understanding with the Biotechnology International Research and Development Centre (BIRD) of Egypt to initiate a research collaboration in the field of marine biotechnology,...
|
|
|
Industrial cultivar first GM approval in more than a decade EU approves biotech spud The first genetically mod
The first genetically modified crop to gain approval in the European Union in more than a decade is a potato.The Amflora potato developed by BASF is not intended for human consumption, but rather for animal feed and industrial use based on its high starch...
|
|
|
ReNeuron inks stem cell manufacturing pact with Angel Biotech
ReNeuron Group plc has signed two further clinical-grade stem cell manufacturing contracts with Angel Biotechnology Holdings plc (Angel), in support of ReNeurons recently approved first-in-man clinical trial with its ReN001 stem cell therapy for stroke...
|
|
|
Biotech ETFs help you profit from the next big thing
March was the 10th anniversary of the beginning of the 'tech wreck' when the NASDAQ peaked at 5132 on March 10, 2000.As we look back ten years and all that has transpired in technology and with the internet, it's also a good time to take a look ahead at what...
|
|
|
Biotech Can Still Be Healthy to Investors
www.rothmanresearch.com- One of the key drivers boosting demand for biotechnology products and services is the readiness for insurers to disburse funds for innovative therapeutics solutions and treatments.For companies to capture those demands and...
|
|
|
Biotechnology sector in 'good heart' post-recession
The organisation representing the New Zealand biotechnology sector say it has emerged from the recession in good heart.NZ Bio chief executive Bronwyn Dilley says despite the financial pressures of the past two years, the number of companies carrying...
|
|
|
17.5 cr for IT, biotech in UoP budget
The University of Pune has laid special focus on information technology and biotechnology in its Rs 308.88-crore budget tabled at its senate meeting on Sunday, wherein an allocation of Rs 17.47 crore has been made for various programmes in these sectors....
|
|
|
Biotech needs shot in the arm
BIOTECHNOLOGY is akin to white-water rafting.It's not for the fainthearted and players are known to have a great appetite for risk and the unexpected. These attributes have served the sector well to date. Biotechnology has proved to be...
|
|
|
Bio Supply Management Alliance Announces 3rd Annual Biotech Supply Chain Academy Conference
The worlds leading community for biotechnology supply chain professionals will be meeting at the Embassy Suites in South San Francisco on October 26, 2010, for the 3rd annual Biotech Supply Chain Academy conference.The expanded multi-track...
|
|
|
Guest opinion: Colonialism lives in biotech seed proposal for Africa
Bill Gates and the biotech juggernauts are doing their best to keep Africa dependent on imported technology, just like in the bad old days of colonialism.Gates, Monsanto and Pioneer have joined the long list of those believing they know best how the...
|
|
|
Biotech industry group spent $1.9M lobbying in 4Q
NEW YORK The Biotechnology Industry Organization spent just under $1.9 million lobbying in the fourth quarter on health care reform efforts that would impact biotech drugs, according to a recent disclosure form.The company also spent about $1.9...
|
|
|
Genzyme spent $750.000 lobbying government in 4Q
Biotech drugmaker Genzyme Corp.spent $750,000 lobbying the federal government in the fourth quarter, according to a recent disclosure form. Genzyme, based in Cambridge, Mass., develops treatments aimed at rare diseases. It joined the ...
|
|
|
Feeding the World: Panel of Renowned Experts Discusses Biotech Options
As the population spirals upward, scientists and policymakers seek ways to both increase research and improve public understanding of agricultural biotechnology's potential contributions to feeding the world.Why does the world embrace biomedical...
|
|
|
Building Biotech Technology Transfer Opportunities: Sponsor and developer strategies for success - new market report published ..
Building Biotech Technology Transfer Opportunities: Sponsor and developer strategies for success - new market report published Refer to a friend 2010-03-19 19:13:05 - Building Biotech Technology Transfer Opportunities: Sponsor and developer...
|
|
|
Top Companies from India's Biotech Industry to Attend BioPartnering India @ Bangalore India Bio!
Top Companies from Indias Biotech Industry to Attend BioPartnering India @ Bangalore India Bio!Santa Cruz, California, United States -- (Business Wire India) -- Wednesday, March 17, 2010 9:55:00 AM Technology Vision Group LLC (TVG) is pleased to...
|
|
|
Building Biotech Technology Transfer Opportunities: Sponsor and developer strategies for success - new market
Drug developers have long been under pressure to introduce new products in an environment of escalating R&D costs, blockbuster patent expiration and resulting generic competition.Current weak economic conditions have exacerbated these challenges with...
|
|
|
1. Top Companies from India's Biotech Industry to Attend BioPartnering
SANTA CRUZ, Calif.-- Technology Vision Group LLC (TVG) is pleased to announce a collaboration with India-based MMActiv, ABLE and the Vision Group on Biotechnology to produce BioPartnering India (BPI) [TM] @ Bangalore India Bio, India's largest ...
AllBusiness Champions of Small Business:
Mar 19 2010 1:13AM
Matching: biotech biotechnolog
|
Find similar documents
|
|
|
|
Amgen spent almost $3.3M lobbying government in 4Q
NEW YORK Biotech drugmaker Amgen Inc.spent nearly $3.3 million lobbying the federal government in the fourth quarter, according to a recent filing. The company, based in Thousand Oaks, Calif., continued a key focus on the proposed regulatory system...
|
|
|
Amgen spent almost $3.3M lobbying government in 4Q
NEW YORK Biotech drugmaker Amgen Inc.spent nearly $3.3 million lobbying the federal government in the fourth quarter, according to a recent filing. The company, based in Thousand Oaks, Calif., continued a key focus on the proposed regulatory system...
|
|
|
BIO Asks Congress to Support Deployment of Biotech Chemical Platforms to Create Green Jobs
Biotechnology Industry Organization WASHINGTON, D.C.- Federal tax policies should incentivize commercial deployment of advanced industrial biotechnologies, which can create jobs, reduce reliance on petroleum, and achieve greenhouse gas reductions...
|
|
|
Amgen spent almost $3.3M lobbying government in 4Q
NEW YORK --Biotech drugmaker Amgen Inc.spent nearly $3.3 million lobbying the federal government in the fourth quarter, according to a recent filing. The company, based in Thousand Oaks, Calif., continued a key focus on the proposed regulatory system...
|
|
|
Amgen spent almost $3.3M lobbying government in 4Q
NEW YORK -- Biotech drugmaker Amgen Inc.spent nearly $3.3 million lobbying the federal government in the fourth quarter, according to a recent filing. The company, based in Thousand Oaks, Calif., continued a key focus on the proposed regulatory...
|
|
|
Amgen spent almost $3.3 million lobbying federal government in fourth quarter
NEW YORK Biotech drugmaker Amgen Inc.spent nearly $3.3 million lobbying the federal government in the fourth quarter, according to a recent filing. The company, based in Thousand Oaks, Calif., continued a key focus on the proposed regulatory system...
|
|
|
Genzyme spent $750.000 lobbying government in 4Q
NEW YORK Biotech drugmaker Genzyme Corp.spent $750,000 lobbying the federal government in the fourth quarter, according to a recent disclosure form. Genzyme, based in Cambridge, Mass., develops treatments aimed at rare diseases. It joined the ...
|
